Rezolute Prices $90 Mln Offering With Common Stock And Pre-Funded Warrants
23/4 22:58
(RTTNews) - Rezolute, Inc. (RZLT), a late-stage biopharmaceutical company focused on rare disease treatments, announced the pricing of an underwritten public offering....